5079 related articles for article (PubMed ID: 6095550)
1. [Dye concentration measurements for the determination of leakage during and following normothermic cytostatic perfusion in the treatment of tumors of the extremities].
Krauss J; Lange U; Pauer HD; Krauss I
Z Exp Chir Transplant Kunstliche Organe; 1984; 17(5):269-74. PubMed ID: 6095550
[TBL] [Abstract][Full Text] [Related]
2. [Regional cytostatic perfusion of the extremities in patients with malignant melanoma and soft tissue sarcoma--therapeutic applications and results].
Eichfeld U; Gläser A; Schneider G; Kraus J; Pauer HJ; Schwarz I
Zentralbl Chir; 1993; 118(2):63-8. PubMed ID: 7682024
[TBL] [Abstract][Full Text] [Related]
3. [Leakage measurements with the dye extraction method and direct methotrexate level determination (enzyme immunoassay) during and after regional cytostatic limb perfusion].
Krauss J; Krause G; Hellthaler G
Z Exp Chir Transplant Kunstliche Organe; 1989; 22(4):260-3. PubMed ID: 2675480
[TBL] [Abstract][Full Text] [Related]
4. [Isolation perfusion chemotherapy using cisplatin in malignant tumors of the extremities].
Takeyama S; Tateishi A; Miki H; Yamanashi M; Hayashi I; Higaki S; Kozima T; Iizima T
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1764-70. PubMed ID: 2543321
[TBL] [Abstract][Full Text] [Related]
5. [Regional hyperthermic cytostatic perfusion as an alternative in the treatment of malignant soft tissue tumors of the extremities].
Ghussen F; Nagel K
Chirurg; 1984 Aug; 55(8):505-7. PubMed ID: 6488995
[TBL] [Abstract][Full Text] [Related]
6. [Combined treatment of malignant tumors of the extremities. Regional perfusion chemotherapy].
Kolessov VI; Levin AO
Minerva Med; 1970 Sep; 61(71):3673-5. PubMed ID: 4989391
[No Abstract] [Full Text] [Related]
7. [Extremity perfusion in malignant melanoma].
Hohenberger W; Meyer T; Göhl J
Chirurg; 1994 Mar; 65(3):175-85. PubMed ID: 8194401
[TBL] [Abstract][Full Text] [Related]
8. [Dye dilution test to determine leakage during regional perfusion in the treatment of malignant tumors of the extremities].
Ghussen F; Isselhard W; Sturz J; Welte CP; Stock W; Müller EW
Chir Forum Exp Klin Forsch; 1979; ():165-8. PubMed ID: 378584
[TBL] [Abstract][Full Text] [Related]
9. Hyperthermia and chemotherapy by regional perfusion for tumors of the extremities.
Cavaliere R; Di Filippo F; Moricca G; Santori F; Varanese A; Cavallari A; Carlini S; Brunori M; Aloe L; Monticelli G
Prog Clin Biol Res; 1982; 107():775-92. PubMed ID: 6962956
[No Abstract] [Full Text] [Related]
10. Cisplatin and platinum pharmacokinetics during hyperthermic isolated limb perfusion for human tumours of the extremities.
Guchelaar HJ; Hoekstra HJ; de Vries EG; Uges DR; Oosterhuis JW; Schraffordt Koops H
Br J Cancer; 1992 Jun; 65(6):898-902. PubMed ID: 1319729
[No Abstract] [Full Text] [Related]
11. Extremity perfusion chemotherapy. Past, present and future.
Serrou B; Romieu C
Panminerva Med; 1976; 18(1-2):14-7. PubMed ID: 1061042
[No Abstract] [Full Text] [Related]
12. Microdialysis and response during regional chemotherapy by isolated limb infusion of melphalan for limb malignancies.
Thompson JF; Siebert GA; Anissimov YG; Smithers BM; Doubrovsky A; Anderson CD; Roberts MS
Br J Cancer; 2001 Jul; 85(2):157-65. PubMed ID: 11461070
[TBL] [Abstract][Full Text] [Related]
13. [Regional perfusion with nitrogen mustard in the treatment of malignant tumors of the lower extremities].
Jelicić I; Pasini M; Prpić I; Relja-Vladović T; Hancević J
Lijec Vjesn; 1969; 91(12):1283-92. PubMed ID: 5269977
[No Abstract] [Full Text] [Related]
14. Systemic and haemodynamic toxicity after isolated limb perfusion (ILP) with TNF-alpha.
Laurenzi L; Natoli S; Di Filippo F; Calamaro A; Centulio F; Anzà M; Cavaliere F; Marcelli ME; Garinei R; Arcuri E
J Exp Clin Cancer Res; 2004 Jun; 23(2):225-31. PubMed ID: 15354406
[TBL] [Abstract][Full Text] [Related]
15. [Hyperthermic isolation perfusion of the extremities in malignant melanomas and soft tissue sarcomas].
Tonak J; Hohenberger W; Göhl J
Chirurg; 1984 Aug; 55(8):499-504. PubMed ID: 6488994
[No Abstract] [Full Text] [Related]
16. [Simplification of surgical technics for venous catheterization in isolated cytostatic drug perfusion of the upper extremity].
Manner M; Göhring U; Schlag P
Chirurg; 1988 Jan; 59(1):41-2. PubMed ID: 3349865
[No Abstract] [Full Text] [Related]
17. [Regional perfusion treatment in primary malignant melanomas of the extremities. (Microstage IV/V according to Clark and tumor thickness over 1.5 mm)].
Schraffordt Koops H; Oldhoff J
Hautarzt; 1982 Sep; 33(9):506-10. PubMed ID: 7174325
[TBL] [Abstract][Full Text] [Related]
18. Hyperthermic perfusion of recurrent malignant melanoma on the extremities.
Hafström L; Jönsson PE
Acta Chir Scand; 1980; 146(5):313-8. PubMed ID: 7468061
[TBL] [Abstract][Full Text] [Related]
19. A phase II trial of isolated limb infusion with melphalan and dactinomycin for regional melanoma and soft tissue sarcoma of the extremity.
Brady MS; Brown K; Patel A; Fisher C; Marx W
Ann Surg Oncol; 2006 Aug; 13(8):1123-9. PubMed ID: 16791448
[TBL] [Abstract][Full Text] [Related]
20. [Clinical results of extremity perfusion in malignant melanoma].
Huber R; Stützer H; Krüger I
Zentralbl Chir; 1996; 121(3):234-42. PubMed ID: 8867351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
